Market Access

Pricing Bulletins
Pricing Bulletins
2021 - Pricing Bulletins
2020 - Pricing Bulletins
2019 - Pricing Bulletins
2018 - Pricing Bulletins
Correction – Supplementary Price Bulletin for Human Use due to voluntary price reductions 06.06.2018
2017 - Pricing Bulletins
2016 - Pricing Bulletins
2015 - Pricing Bulletins
2014 - Pricing Bulletins
2013 - Pricing Bulletins
2012 - Pricing Bulletins
2011 - Pricing Bulletins
2010 - Pricing Bulletins
2009 - Pricing Bulletins
2008 - Pricing Bulletins
2007 - Pricing Bulletins
2006 - Pricing Bulletins
2005 - Pricing Bulletins
2004 - Pricing Bulletins
2003 - Pricing Bulletins
2002 - Pricing Bulletins
2001 - Pricing Bulletins
2000 - Pricing Bulletins
1999 - Pricing Bulletins
1998 - Pricing Bulletins
1997 - Pricing Bulletins
1996 - Pricing Bulletins
1995 - Pricing Bulletins
1994 - Pricing Bulletins
Pricing Determination
Draft Law re: “Regulation of matters relating to the National Health System, pharmaceuticals, pharmacies, and other provisions”-Translation
22.11.2011 – New Ministerial Decision “Provisions of pricing of medicinal products”-Translation
21.06.2011 – Observations of SFEE on the draft ministerial decision on pricing of medicinal products
16.05.2011 – Ministerial Decision regarding new wholesale margin and abolishment of discounts
Announcement by the Secretariat General of Commerce – Pharmaceutical Products under Law 3816/2010
01.09.2010 – Translation of Market Decree 8/2010 – SUBJECT: “Amendment of articles 334,336, 340 and 342 of Chapter 27 “MEDICINES” of Market Decree 7/2009 as in force”
05.08.2010 – Amendment of articles 331, 333 of Chapter “MEDICINES” of Market Decree 7/2009 as in force – Market Decree No7
06.04.2010 – Translation of the Letter sent to the Minister of Economy, Competitiveness and Shipping
Amendment of certain articles of Chapter 27 “Medicines” of the Market Decree 7/09 & 8/09 (Translation of Market Decree No. 2)
16.02.2010 – Translation of Press Release by the Ministry of Economy about the Medicinal Products Price Determination Policy
Reimbursement
Ministerial Decision No. DYG3 (a)/oik.104744 entitled: Implementation of a reference pricing system for drawing up, revising and supplementing the list of reimbursed pharmaceutical products”
E-prescription
Claw back – Rebate
Hospital Debts / EOPYY
31.08.2022 – A Report on State’s Debts towards SFEE’s Member-Companies: € ~ 659.6 mio
31.05.2022 – A Report on State’s Debts towards SFEE’s Member-Companies: € ~ 714.5 mio
28.02.2022 – A Report on State’s Debts towards SFEE’s Member-Companies: € ~ 611.7 mio
31.01.2022 – A Report on State’s Debts towards SFEE’s Member-Companies: € ~ 576.2 mio
31.5.2014 – Total Sales, Sums collected and Sums still Pending by the State towards SFEE’s Member Companies: ≈ €1.050 mil.
30.4.2014 – Total Sales, Sums collected and Sums still Pending by the State towards SFEE’s Member Companies: ≈ €1.020 mil.
31.3.2014 – Total Sales, Sums collected and Sums still Pending by the State towards SFEE’s Member Companies: ≈1,050 mil.
28.2.2014 – Total Sales, Sums collected and Sums still Pending by the State towards SFEE’s Member Companies: ≈1,070 mil.
31.1.2014 – Total Sales, Sums collected and Sums still Pending by the State towards SFEE’s Member Companies: ≈€995mil.
31.12.2013 – Total Sales, Sums collected and Sums still Pending by the State towards SFEE’s Member Companies: ≈€970 mil.
30.11.2013 – Total Sales, Sums collected and Sums still Pending by the State towards SFEE’s Member Companies: ≈€1.050 bil.
31.10.2013 – Total Sales, Sums collected and Sums still Pending by the State towards SFEE’s Member Companies: ≈€1.150 bil.
30.9.2013 – Total Sales, Sums collected and Sums still Pending by the State towards SFEE’s Member Companies: ≈€1bil.200 mil.
31.8.2013 – Total Sales, Sums collected and Sums still Pending by the State towards SFEE’s Member Companies: ≈€1.200 mil.
30.6.2013 – Total Sales, Sums collected and Sums still Pending by the State towards SFEE’s Member Companies: ≈€1.390 bil.
31.5.2013 – Total Sales, Sums collected and Sums still Pending by the State towards SFEE’s Member Companies: ≈ €1.470 bil.
Regarding the off-setting of the rebate amount due (9% & volume) by pharmaceutical companies with hospital debts
ΟJ 262/A/16.12.2011 – Off-setting of the entry ticket and the 2011 rebate – Inofficial translation
9.6.2010 – Joint Press Release by the Ministry of Finance and the Ministry of Health & Public Solidarity regarding the settlement of hospital debts
10.5.2010 – Translation of the Letter sent to Mr. Elias Plaskovitis, Secretary General of the Ministry of Finance, President of the Committee of Hospital Debts and to Mr. Nikolaos Polyzos, Secretary General of the Ministry of Health and Social Solidarity
March 13, 2009 – SFEE’s informative Letter addressed to the Directors General of SFEE Member Companies regarding Hospital Debts
EOF Topics
Following SFEE's BoD decision, SFEE's SPCs mini-site set to offline status due to EOF's corresponding e-platform.
We would like to inform you that at the following link you are leaving SFEE’s site and redirect to EOF’s site.
Via Menu ‘Human’>Search you can find information re pharmaceutical products by choosing the Product name, Active Ingredients, ATC or Company
Subsequently, from the browser you can find the requested information.
In the documentation section you will find online the Summary of Product Characteristics (SPC) and the Patient Leaflet (PL), and if there is the link of Public Assessment Report